Treatment Options and Daily Management

Managing ochronosis is a long-term commitment that focuses on slowing the buildup of pigment and improving your quality of life. Because the causes of the genetic (AKU) and acquired (EO) forms are so different, the strategies for treating them are equally distinct ^[1][2].

Treating Exogenous Ochronosis (EO)

Exogenous ochronosis is notoriously difficult to treat because the pigment is physically trapped deep within the skin’s layers ^[3].

• The First Step: You must immediately stop using any skin-lightening products containing hydroquinone, phenol, or resorcinol ^[3]. Continuing these products can worsen the condition ^[2]. Ask your prescriber how to safely adjust your skincare.
• Sun Protection: Strict daily use of broad-spectrum sunscreen and sun-protective clothing is essential to prevent further darkening ^[3].
• Dermatological Options: Various treatments have been tried with mixed results. These include Q-switched lasers (like the Alexandrite or Nd:YAG), picosecond lasers, and microneedling ^[4]. It is important to have realistic expectations; many patients see only partial improvement, and these cosmetic procedures should be performed by a dermatologist experienced with your skin type, as they carry risks of causing further pigment changes or scarring ^[4].

Disease-Modifying Therapy for AKU: Nitisinone

A disease-modifying therapy for treating Alkaptonuria (AKU) is a medication called nitisinone.

• How It Works: Nitisinone is an enzyme inhibitor that blocks the production of homogentisic acid (HGA) ^[5]. In the major SONIA 2 clinical trial, taking 10 mg of nitisinone daily reduced HGA in the urine by 99.7% within one year ^[5].
• What to Expect: Nitisinone was associated with a slower overall progression of clinical severity in the trial ^[5]. However, this biochemical reduction of HGA does not guarantee that it will reverse existing joint damage or clear pigment that is already embedded in your tissues ^[5][6].
• Availability and Dosing: Approval, availability, and off-label status of nitisinone vary by country. Dosing decisions (such as 2 mg or 10 mg) are complex and made by a specialist, balancing maximum HGA suppression against the increased risk of drug-related side effects ^[7].
• Safety Warnings: Nitisinone requires prescription specialist follow-up. Safety during pregnancy, breastfeeding, or in pediatric patients requires direct discussion with your metabolic specialist.

The Critical Role of Diet

When you take nitisinone, your body’s levels of the amino acid tyrosine will naturally rise. If these levels get too high, you can develop corneal keratopathy—tiny crystals in the eye that can cause irritation and, if left untreated, vision issues ^[7][8].

• Do Not Restrict Diet on Your Own: Simply restricting protein without taking nitisinone does not significantly lower HGA or slow down the disease; the diet is primarily a tool to make nitisinone therapy safer ^[9][10]. Tell your doctor before starting any restricted diet. Unsupervised protein restriction can cause malnutrition and dangerous loss of muscle mass.
• Dietitian Supervision: It is vital to work with a specialized metabolic dietitian to safely follow a low-protein diet (specifically low in tyrosine and phenylalanine) ^[11].
• Amino Acid Supplements: To preserve calories, growth, and muscle mass, your dietitian may prescribe specialized tyrosine-free and phenylalanine-free amino acid supplements ^[12][13].

Supportive Care and Joint Replacement

Because nitisinone cannot fix existing damage, many patients require additional support for their joints.

• Physical Therapy: Low-impact exercise, occupational therapy, and specialized physical therapy can help maintain flexibility and manage pain.
• Pain Management: Your care team may recommend anti-inflammatory medications or other non-opioid pain strategies tailored to chronic ochronotic arthritis.
• Joint Replacement: When joint damage becomes severe, hip and knee replacements have generally shown favorable outcomes based on small case series in patients with ochronosis ^[14][15]. These surgeries improve mobility and reduce pain, but carry ordinary surgical risks ^[14]. Surgeons must be aware that ochronotic tissue can be more fragile than usual, requiring extra care during the procedure ^[16][17].